ME LD697 | 2025-2026 | 132nd Legislature
Status
Spectrum: Partisan Bill (Democrat 7-0)
Status: Introduced on February 20 2025 - 25% progression
Action: 2025-02-20 - Received by the Secretary of the Senate on February 20, 2025 and REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES pursuant to Joint Rule 308.2
Pending: Joint Health Coverage, Insurance and Financial Services Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 20 2025 - 25% progression
Action: 2025-02-20 - Received by the Secretary of the Senate on February 20, 2025 and REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES pursuant to Joint Rule 308.2
Pending: Joint Health Coverage, Insurance and Financial Services Committee
Text: Latest bill text (Introduced) [PDF]
Summary
An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing
Title
An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing
Sponsors
| Sen. Cameron Reny [D] | Sen. Donna Bailey [D] | Sen. Henry Ingwersen [D] | Rep. Anne-Marie Mastraccio [D] |
| Rep. Kristi Mathieson [D] | Sen. Joseph Rafferty [D] | Sen. Denise Tepler [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2025-02-20 | Senate | Received by the Secretary of the Senate on February 20, 2025 and REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES pursuant to Joint Rule 308.2 |
Subjects
Maine State Sources
| Type | Source |
|---|---|
| Summary | https://legislature.maine.gov/legis/bills/display_ps.asp?LD=697&snum=132 |
| Text | https://legislature.maine.gov/legis/bills/getPDF.asp?paper=SP0314&item=1&snum=132 |
